Reply to M.S. Copur et al and to M.C. Chamberlain

Affiliations

Comment

Joseph N Contessa et al. J Clin Oncol. 2016.

. 2016 Jul 1;34(19):2316-7.

doi: 10.1200/JCO.2016.67.2816. Epub 2016 Apr 25.

No abstract available

Comment on

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Johung KL, et al. J Clin Oncol. 2016 Jan 10;34(2):123-9. doi: 10.1200/JCO.2015.62.0138. Epub 2015 Oct 5. J Clin Oncol. 2016. PMID: 26438117 Free PMC article.
Is It Time to Reconsider Prophylactic Cranial Radiation in Non-Small-Cell Lung Cancer?
Copur MS, Ramaekers R, Clark D, Norvell M, Gauchan D. Copur MS, et al. J Clin Oncol. 2016 Jul 1;34(19):2314. doi: 10.1200/JCO.2015.65.2974. Epub 2016 Apr 25. J Clin Oncol. 2016. PMID: 27114597 No abstract available.
Targetable Lung Cancer Brain Metastases: Improved Outcome.
Chamberlain MC. Chamberlain MC. J Clin Oncol. 2016 Jul 1;34(19):2315. doi: 10.1200/JCO.2016.66.9465. Epub 2016 Apr 25. J Clin Oncol. 2016. PMID: 27114601 No abstract available.